Navigation Links
Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
Date:5/13/2013

or 510.856.5598.

 ANTHERA PHARMACEUTICALS, INC.(A Development Stage Company)CONDENSED STATEMENTS OF OPERATIONS (in thousands, except share and per share data)(unaudited)Three Months Ended March 31,20132012Operating expenses:Research and development

$

4,929

(1)$

17,738General and administrative1,972

(2)2,322Total operating expenses6,90120,060Loss from operations(6,901)(20,060)Other income (expenses):Other income (expense) - net25(10)Interest expense(704)(843)Total other (expense) - net(679)(853)Net loss attributable to common stockholders

$

(7,580)$

(20,913)Net loss per share attributable to common stockholders:Basic and diluted

 

$

 

(0.06) 

$

 

(0.51)Weighted-average number of shares used to compute net loss per share of common stock—basic and diluted 

124,124,066 

41,000,421(1)

Included in research and development expenses is a one-time charge of stock-based compensation of approximately $799,000 associated with the voluntary surrender of stock options by our employees during the three months ended March 31, 2013.(2)

Included in general and administrative expenses is a one-time charge of stock-based compensation of approximately $661,000 associated with the voluntary surrender of stock options by our employees during the three months ended March 31, 2013. 

 ANTHERA PHARMACEUTICALS, INC.(A Development Stage Company)BALANCE SHEET DATA(in thousands, except share data)(unaudited)March 31, 2013December 31,
2012Cash and cash equivalents

$
50,570$
9,431Short term investments

$
3,824$
5,322Total assets

$
56,452$
26,445Total current liabilities, excluding current portion of notes payable

$
4,706$
9,421Total notes payable

$
8,393$
20,550Deficit accumulated during development
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
2. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
3. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
4. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
5. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
6. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
7. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
8. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
9. Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
10. Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
11. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led by ... a premier and affordable laser tattoo removal experience with the ... focus is in providing high quality cosmetic services with cutting edge ... " Southern California has seen a dramatic ...
(Date:1/14/2014)... 14, 2014 NineSigma , Inc., the leading ... Innovation Leadership Summit , May 14-16, 2014 at the ... Ohio . This is the ... to breakthrough achievements through open innovation. Participants will learn ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... Colo., Jan. 12, 2012 Biosyntrx, Inc. CEO Ellen ... to the Biosyntrx Board of Directors.  Mr. Feher lives ... engineering with an MBA from the University Of Southern ... Biosyntrx strategic planning consultant for the past two years.  ...
... 2012 CVS Caremark Corporation will pay $5 million ... the prices of certain Medicare Part D prescription drugs ... and epilepsy – at CVS and Walgreens pharmacies.  The ... to pay significantly more for their drugs than they ...
Cached Medicine Technology:Biosyntrx, Inc. Appoints New Board Member & New VP of Operations 2CVS Caremark Corporation Settles FTC Deceptive Pricing Charges 2CVS Caremark Corporation Settles FTC Deceptive Pricing Charges 3CVS Caremark Corporation Settles FTC Deceptive Pricing Charges 4
(Date:4/24/2014)... LA The National Science Foundation has awarded ... Experiences for Undergraduates (REU) Site grant in the ... training of undergraduates from diverse social and educational ... New Orleans area. The project will provide ... summers of 2014-16. It will be led ...
(Date:4/23/2014)... Using frozen stool from healthy, unrelated donors was ... relapsing diarrhea caused by Clostridium difficile , ... Clinical Infectious Diseases and available online. ... equally effective whether given via a colonoscope or ... may make this promising treatment more readily available ...
(Date:4/23/2014)... the National Institute of Arthritis and Musculoskeletal and Skin ... the Ross Prize in Molecular Medicine, conferred by the ... The award will be given on June 9 at ... by scientific presentations by Dr. O,Shea and other prominent ... Health. , The award, which includes a $50,000 prize ...
(Date:4/23/2014)... have developed a way to detect and measure cancer ... particles with tails of synthetic DNA., A team led ... used gold nanoparticles to target and bind to fragments ... variants, which can indicate the presence and stage of ... in a cell can be determined by examining the ...
(Date:4/23/2014)... 23, 2014Men whose testosterone falls below normal levels are ... overweight and have heart disease and type 2 diabetes. ... men for further testing and possible treatment is described ... , a peer-reviewed publication from Mary Ann Liebert, Inc., ... Journal of Men,s Health website at http://www.liebertpub.com/jmh ...
Breaking Medicine News(10 mins):Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:Gold nanoparticles help target, quantify breast cancer segments in a living cell 2
... with life? Then the pen may be a mighty ... Dr. Steven Toepfer. , Toepfer, an assistant professor of ... that expressive writing is something that has been available ... than 4,000 years ago. , "Everyone is pursuing the ...
... Donation Goal and Collects 1.5 Million Pounds of Food for ... NEW YORK, Nov. 25 Weight Watchers (NYSE: ... one million dollars to two hunger fighting organizations -- Share ... made possible by the success of Weight Watchers Members and ...
... at the U.S. Department of Energy,s (DOE) Brookhaven National ... for the design of a "medical synchrotron" capable of ... with minimal damage to surrounding healthy tissue. The new ... existing proton-therapy systems, potentially increasing the availability and benefits ...
... Dr. Robert J. Caccavaleof Somerset-based Thoracic Group P.A. for Excellence, ... N.J., Nov. 25 Thoracic Group P.A. ( www.thoracicgroup.com ) ... been named a Top Thoracic Surgeon in New Jersey by ... Caccavale, featured in New Jersey Monthly,s ...
... 25 MINRAD International, Inc. (Amex: ... terminated its Distribution Agreement for anesthetics for the human ... a wholly-owned subsidiary of RxElite Inc.(OTC Bulletin Board: RXEI) ... a result of RxElite,s failure to provide payment in ...
... work woes to fatal cardiovascular events in men , , ... overbearing boss? Your heart may pay the price, according ... workers, risks for angina, heart attack and death rose ... "This study is the first to provide evidence of ...
Cached Medicine News:Health News:Study: Want to be happier? Be more grateful 2Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 2Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 3Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 4Health News:Physicists receive patent for improved cancer therapy device 2Health News:Physicists receive patent for improved cancer therapy device 3Health News:Renowned Thoracic Surgeon Recognized as 'Top Doctor' by Peers in Annual New Jersey Monthly Magazine Survey 2Health News:MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States 2Health News:MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States 3Health News:Bad Bosses Are Hard on the Heart 2Health News:Bad Bosses Are Hard on the Heart 3Health News:Bad Bosses Are Hard on the Heart 4
... Original Knee Brace gives fracture treatment patients ... control, this brace features the the Bledsoe ... from 0-120, and positively locks at any ... eccentric cam slots, the Bledsoe Multi-Centric Hinge ...
The Bledsoe Post-Op Knee Brace is designed to provide maximum protection without sacrificing comfort and quick, easy application....
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
Medicine Products: